RESUMO
Background:Diabetic patients with foot ulcer constitute the majority of hospital admissions. Unless treated appropriately a worsening infection can set of a chain of events, a spreading infection which penetrates into the deep soft tissue excites cellulitis, produces necrosis and gangrene and eventually necessitates the amputation of limb. Management of established foot ulcer lesion is multidisciplinary and even demands expertise in surgery, endocrinology, podiatry, orthopedics, vascular surgery, neurology, infectious disease. Platelet-derived growth factor (PDGF) is one of the numerous growth factors that regulate cell growth and division, in particular angiogenesis. PDGF promote formation of granulation tissue and thus stimulate cutaneous ulcer healing. Methods: A study was conducted on 50 patients to compare the outcome and efficacy of topical PDGF v/s EUSOL in healing of diabetic foot ulcer. Result: 50 patients of diabetic of diabetic foot ulcer werestudied, divided into two groups of 25 each. One group received PDGF and other group received EUSOL. It was observed that patient receiving PDGF had better wound contraction of 39.55% as compared to group receiving EUSOL in whom the mean wound contraction was 11.79%. Conclusion: PDGF dressing therapy in the treatment of diabetic foot ulcer was found to be more effective, safe, promoter of wound healing.